Bidirectional Association between Sarcopenia and Depressive Symptoms among Chinese Middle- and Older-Aged Adults: Longitudinal Observational Study
Open Access
- 11 June 2024
- journal article
- research article
- Published by MDPI AG in Brain Sciences
- Vol. 14 (6) , 593
Abstract
Background: The study aimed to examine the bidirectional relationship between sarcopenia and depressive symptoms in a national, community-based cohort study, despite the unclear temporal sequence demonstrated previously. Methods: Data were derived from four waves (2011 baseline and 2013, 2015, and 2018 follow-ups) of the China Health and Retirement Longitudinal Study (CHARLS). A total of 17,708 participants aged 45 years or older who had baseline data on both sarcopenia status and depressive symptoms in 2011 were included in the study. For the two cohort analyses, a total of 8092 adults without depressive symptoms and 11,292 participants without sarcopenia in 2011 were included. Sarcopenia status was defined according to the Asian Working Group for Sarcopenia 2019 (AWGS 2019) criteria. Depressive symptoms were defined as a score of 20 or higher on the 10-item Center for Epidemiologic Studies Depressive Scale (CES-D-10). Cox proportional hazard regression models were conducted to examine the risk of depressive symptoms and sarcopenia risk, while cross-lagged panel models were used to examine the temporal sequence between depressive symptoms and sarcopenia over time. Results: During a total of 48,305.1 person-years follow-up, 1262 cases of incident depressive symptoms were identified. Sarcopenia exhibited a dose–response relationship with a higher risk of depressive symptoms (HR = 1.7, 95%CI: 1.2–2.3 for sarcopenia, and HR = 1.5, 95%CI: 1.2–1.8 for possible sarcopenia, p trend < 0.001). In the second cohort analysis, 240 incident sarcopenia cases were identified over 39,621.1 person-years. Depressive symptoms (HR = 1.5, 95%CI: 1.2–2.0) are significantly associated with a higher risk of developing sarcopenia after multivariable adjustment (p < 0.001, Cross-lagged panel analyses demonstrated that depressive symptoms were associated with subsequent sarcopenia (β = 0.003, p < 0.001). Simultaneously, baseline sarcopenia was also associated with subsequent depressive symptoms (β = 0.428, p < 0.001). Conclusion: This study identified a bidirectional relationship between depressive symptoms and sarcopenia. It seems more probable that baseline sarcopenia is associated with subsequent depressive symptoms in a stronger pattern than the reverse pathway. The interlinkage indicated that maintaining normal muscle mass and strength may serve as a crucial intervention strategy for alleviating mood disorders.Keywords
Funding Information
- National Key Research and Development Program of China (2019YFA0706200, 2021YFC0863700, STI2030-Major Projects, 2021ZD0200800, 2021ZD0200700, 82288101, 82171514, BMU2022DJXK007)
- National Programs for Brain Science and Brain-like Intelligence Technology of China (2019YFA0706200, 2021YFC0863700, STI2030-Major Projects, 2021ZD0200800, 2021ZD0200700, 82288101, 82171514, BMU2022DJXK007)
- National Natural Science Foundation of China (2019YFA0706200, 2021YFC0863700, STI2030-Major Projects, 2021ZD0200800, 2021ZD0200700, 82288101, 82171514, BMU2022DJXK007)
- Fundamental Research Funds for the Central Universities (2019YFA0706200, 2021YFC0863700, STI2030-Major Projects, 2021ZD0200800, 2021ZD0200700, 82288101, 82171514, BMU2022DJXK007)
This publication has 69 references indexed in Scilit:
- Sarcopenia and mild cognitive impairment among elderly adults: The first longitudinal evidence from CHARLSJournal of Cachexia, Sarcopenia and Muscle, 2022
- Association Between Physical Activity and Risk of DepressionJAMA Psychiatry, 2022
- Pathogenesis of sarcopenia and the relationship with fat mass: descriptive reviewJournal of Cachexia, Sarcopenia and Muscle, 2022
- Prevalence of depression in patients with sarcopenia and correlation between the two diseases: systematic review and meta‐analysisJournal of Cachexia, Sarcopenia and Muscle, 2022
- Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysisJournal of Cachexia, Sarcopenia and Muscle, 2021
- Vitamin D 3 supplementation does not enhance the effects of resistance training in older adultsJournal of Cachexia, Sarcopenia and Muscle, 2021
- Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adultsJournal of Cachexia, Sarcopenia and Muscle, 2020
- Association of Depression With All-Cause and Cardiovascular Disease Mortality Among Adults in ChinaJAMA Network Open, 2020
- Assessment of Sarcopenia Among Community-Dwelling At-Risk Frail Adults Aged 65 Years and Older Who Received Multidomain Lifestyle InterventionsJAMA Network Open, 2019
- Sarcopenia predicts readmission and mortality in elderly patients in acute care wards: a prospective studyJournal of Cachexia, Sarcopenia and Muscle, 2016